Clinical and histologic remission achieved with upadacitinib in a patient with refractory eosinophilic gastritis and duodenitis
The Journal of Allergy and Clinical Immunology: In Practice · 2024
DOI: 10.1016/j.jaip.2024.02.031 ↗Kurz gefasst
Fallbericht in der Zeitschrift The Journal of Allergy and Clinical Immunology: In Practice, 2024. Verfasst von Jerry Fu und 20 weiteren Autor:innen. Beteiligte Einrichtung: Boston Specialists, Boston, Mass. Hauptthemen laut MEDLINE: Duodenitis, Eosinophilia, Gastritis. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 9 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Eosinophilic gastrointestinal diseases (EGIDs) are chronic inflammatory diseases characterized by eosinophilic invasion of the gastrointestinal tract. Patients with noneosinophilic esophagitis (EoE) EGIDs commonly present with abdominal pain, nausea, and other gastrointestinal symptoms.1 Current accepted histologic cutoffs for eosinophilic gastritis (EoG) and duodenitis (EoD) are 30 peak eosinophils or greater per high-power field (eos/hpf) in at least 5 hpfs in the gastric body or antrum and 30 eos/hpf or greater in at least 3 hpf in the duodenum, respectively.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Boston Specialists, Boston, Mass.
- School of Medicine, Stanford University, Stanford, Calif.
- School of Medicine, University of Connecticut, Storrs, Conn.
- Department of Pathology & Lab Services, Carney Hospital, Dorchester, Mass.
- Boston Specialists, Boston, Mass. Electronic address: drjohnleung@bfac.org.
Zitieren
APA
Fu, J., Sia, T., Solecki, R., Mallik, S., Khuda, R., Headen, M., Bacchus, L., Zheng, M., Telukunta, T., Shami, S., Liu, S., Sureshbabu, S., Love, K., Roby, A., McDonald, P., Jiang, Y., Narayanan, D. H., Cunningham, E., Matmatte, A. S., …, & Leung, J. (2024). Clinical and histologic remission achieved with upadacitinib in a patient with refractory eosinophilic gastritis and duodenitis. The Journal of Allergy and Clinical Immunology: In Practice. https://doi.org/10.1016/j.jaip.2024.02.031
Vancouver
Fu J, Sia T, Solecki R, Mallik S, Khuda R, Headen M, et al. Clinical and histologic remission achieved with upadacitinib in a patient with refractory eosinophilic gastritis and duodenitis. The Journal of Allergy and Clinical Immunology: In Practice. 2024. doi:10.1016/j.jaip.2024.02.031
BibTeX
@article{Fu2024,
author = {Fu, Jerry and Sia, Twan and Solecki, Rachel and Mallik, Shibani and Khuda, Raisa and Headen, Madison and Bacchus, Leeon and Zheng, Michelle and Telukunta, Tanvi and Shami, Saad and Liu, Stanley and Sureshbabu, Sripad and Love, Kathleen and Roby, Alyssa and McDonald, Paige and Jiang, Yuting and Narayanan, Dharaneswari Hari and Cunningham, Evan and Matmatte, Amina Sara and Tan, Puay Eng and Leung, John},
title = {Clinical and histologic remission achieved with upadacitinib in a patient with refractory eosinophilic gastritis and duodenitis},
journal = {The Journal of Allergy and Clinical Immunology: In Practice},
year = {2024},
doi = {10.1016/j.jaip.2024.02.031}
}
EUVIMED